At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
can help you move forward
A human putative lymphocyte G0/G1 switch gene containing a CpG-Rich island encodes a small basic protein with the potential to be phosphorylated
Each package is securely prepared, shipped discreetly, and supported with tracking for reliable fulfillment
When they started her loading doses I believe they gave her three injections, one a week for 3 weeks, and then they went to every other week but now they've changed her back to every week because they said her B12 hasn't come up enough
Progess photos
